🇺🇸 FDA
Patent

US 7964591

Pyridazine derivatives and their use as therapeutic agents

granted A61KA61K31/00A61K31/501

Quick answer

US patent 7964591 (Pyridazine derivatives and their use as therapeutic agents) held by Xenon Pharmaceuticals Inc. expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Xenon Pharmaceuticals Inc.
Grant date
Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/00, A61K31/501, A61K31/551, A61P